Light and challenges: Advances in targeted therapy for glioma
Journal Title: Chinese Journal of Nervous and Mental Diseases - Year 2025, Vol 51, Issue 1
Abstract
Glioma is the most common malignant primary brain tumor in adults, characterized by rapid malignant progression, high recurrence rates, and high mortality. The main treatment methods are surgery followed by radiotherapy and chemotherapy. Temozolomide, as the first-line drug for glioma treatment, is exposed to increasingly severe issues with drug resistance, which significantly impacts the efficacy and prognosis for glioma patients. With advancements in molecular biomarker detection and the emergence of precision medicine, targeted and individualized treatment strategies for glioma patients are evolving rapidly. The discovery of new glioma biomarkers, such as long non-coding RNA HOTAIR (HOX antisense intergenic RNA), polymerase I and transcript release factor (PTRF/Cavin1), and MET, along with the application of new technologies like computer-aided drug design (CADD), has ushered in a new era for the design and development of targeted drugs for glioma. Due to the heterogeneity of glioma, the effectiveness of single-target drugs is limited. In the future, a combination of physical, chemical, and biological interventions will be the breakthrough direction for glioma treatment.
Authors and Affiliations
Dongyuan SU, Chunsheng. KANG
Keywords
Related Articles
- EP ID EP762093
- DOI 10.3969/j.issn.1002-0152.2025.01.001
- Views 33
- Downloads 0
Tubular aggregates in systemic lupus erythematosus: A case report and review of literature
Tubular aggregates (TA) are ultrastructural abnormalities in muscle biopsies, which can be detected in muscle biopsy specimens from patients with a variety of hereditary and acquired disorders. A 34-year-old male patient...
A case report of tuberculous meningoencephalitis with anti-neurexin-3α antibody-associated encephalitis
The clinical manifestations of tuberculous meningoencephalitis (TBME) are varied, and diagnostic tests for Mycobacterium tuberculosis show limited sensitivity and specificity, often failing to provide timely diagnostic s...
Advances in the diagnosis and treatment of chronic subdural hematoma
Chronic subdural hematoma is one of the common central nervous system diseases in middle-aged and elderly people, and the incidence is increasing year by year. Drill and drain surgery is recognized as one of the effectiv...
Recommendations on clinical application of deutetrabenazine for treatment of tardive dyskinesia
Deutetrabenazine (DTBZ) is a selective oral small molecule inhibitor of vesicular monoamine transporter 2 (VMAT2). Its pharmacological action works by inhibiting VMAT2, thereby reducing the release of presynaptic dopamin...
Research progress on bipolar disorder and pregnancy complications and neonatal risk.
Pregnant women with bipolar disorder (BD) are a high-risk pregnancy state. Necessary psychotropic drug treatment, special stress reactions, bad living habits, and fluctuations in pregnancy hormones all increase the risk...